How Alnylam's Raised 2025 Revenue Outlook and AMVUTTRA Uptake Will Impact ALNY Investors [Yahoo! Finance]
Alnylam Pharmaceuticals, Inc. (ALNY)
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.alnylam.com/investor-overview
Company Research
Source: Yahoo! Finance
million, while also raising full-year revenue guidance to between US$2.95 billion and US$3.05 billion. This performance marks a major turnaround from the same period last year, driven by strong uptake of AMVUTTRA and growth across its RNAi therapeutics portfolio. We'll assess how Alnylam's updated 2025 revenue outlook, following AMVUTTRA's strong momentum, reshapes the company's investment narrative. The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's. Alnylam Pharmaceuticals Investment Narrative Recap To be a shareholder in Alnylam Pharmaceuticals, you need conviction in its ability to maintain AMVUTTRA's strong growth and broaden the reach of its RNAi pipeline, all while managing risks from revenue concentration and pricing pressure. The sharp profit turnaround and upbeat guidance in the latest quarter materially reinforce the near-term importance of AMVUTTRA's launch
Show less
Read more
Impact Snapshot
Event Time:
ALNY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALNY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALNY alerts
High impacting Alnylam Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ALNY
News
- Do Alnylam Pharmaceuticals' (ALNY) Board Moves Quietly Reframe Its Management Incentives and Risk Profile? [Yahoo! Finance]Yahoo! Finance
- Alnylam Pharmaceuticals Announces Changes to Board of DirectorsBusiness Wire
- Spotlight On Alnylam Pharmaceuticals And 2 Other Stocks Possibly Trading Below Fair Value [Yahoo! Finance]Yahoo! Finance
- Thanksgiving: Top 10 Most Innovative BioPharma Drugs In Phase 3 [Seeking Alpha]Seeking Alpha
- Alnylam Pharmaceuticals (ALNY): Assessing Valuation After Recent Share Price Pullback [Yahoo! Finance]Yahoo! Finance
ALNY
Earnings
- 10/30/25 - Beat
ALNY
Sec Filings
- 12/3/25 - Form 8-K
- 12/1/25 - Form 4
- 11/19/25 - Form 4
- ALNY's page on the SEC website